Mawer Investment Management
WST icon

Mawer Investment Management’s West Pharmaceutical WST Stock Holding History

Mawer Investment Management’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-61,966
Closed -$25.4M – 113
2022
Q1 		$25.4M Sell
61,966
-16,073
-21% -$6.29M 0.12% 78
2021
Q4 		$36.6M Sell
78,039
-16,753
-18% -$7.21M 0.16% 78
2021
Q3 		$40.2M Sell
94,792
-23
-0% -$9.7K 0.19% 78
2021
Q2 		$34M Sell
94,815
-38,772
-29% -$12.8M 0.17% 79
2021
Q1 		$37.6M Buy
133,587
+252
+0.2% +$72.1K 0.2% 76
2020
Q4 		$37.8M Sell
133,335
-289
-0.2% -$81.1K 0.22% 73
2020
Q3 		$36.7M Sell
133,624
-24,885
-16% -$6.59M 0.24% 67
2020
Q2 		$36M Sell
158,509
-23,023
-13% -$4.52M 0.27% 60
2020
Q1 		$27.6M Sell
181,532
-27,110
-13% -$4.17M 0.25% 62
2019
Q4 		$31.4M Sell
208,642
-16,116
-7% -$2.35M 0.25% 61
2019
Q3 		$31.9M Sell
224,758
-71,667
-24% -$9.87M 0.29% 59
2019
Q2 		$37.1M Buy
296,425
+6,200
+2% +$732K 0.24% 74
2019
Q1 		$32M Sell
290,225
-140
-0% -$14.6K 0.23% 69
2018
Q4 		$28.5M Sell
290,365
-23,435
-7% -$2.54M 0.24% 71
2018
Q3 		$38.7M Buy
313,800
+900
+0.3% +$101K 0.29% 68
2018
Q2 		$31.1M Buy
312,900
+39,094
+14% +$3.6M 0.25% 73
2018
Q1 		$24.2M Buy
273,806
+247,541
+942% +$23.2M 0.2% 77
2017
Q4 		$2.59M Sell
26,265
-20
-0.1% -$1.96K 0.02% 108
2017
Q3 		$2.53M Buy
+26,285
New +$2.38M 0.02% 104

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $40.7B AUM 39.97% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Mawer Investment Management's WST Position: Q2 2022 in Review

Mawer Investment Management sold out of West Pharmaceutical (WST) in Q2 2022, closing a stake of 61,966 shares — an estimated $25.4M sold.

Mawer Investment Management first reported a position in WST in Q3 2017 and held it in 19 quarters. The position peaked at $40.2M in Q3 2021. 655 funds tracked by Wall St. Rank hold WST as of Q2 2022.

  • Mawer Investment Management reported no remaining West Pharmaceutical position as of Q2 2022 after selling out during the quarter.
  • Mawer Investment Management sold 61,966 West Pharmaceutical shares in Q2 2022, an estimated $25.4M.
  • Mawer Investment Management first reported a position in West Pharmaceutical in Q3 2017 and held it in 19 quarters.
  • Mawer Investment Management's West Pharmaceutical position peaked at $40.2M in Q3 2021.
  • 655 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2022.

Based on Mawer Investment Management's 13F filing for Q2 2022, filed 9 Aug 2022.